NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Ap... ( DUBAI United Arab Emirates Sept. 20 /...)

HOME >> MEDICINE >> TECHNOLOGY

NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments

Date:9/20/2010

DUBAI, United Arab Emirates, Sept. 20 /PRNewswire/ -- NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that Joseph W. Henein has been appointed President and Chief Executive Officer and a member of the company's Board of Directors. Mr. Henein is a senior executive who joins NewBridge after a career extending over 29 years in multinational pharmaceutical corporations, holding a number of senior positions covering many geographies including; US, Europe, and Middle East.

Most recently Mr. Henein was the head and Managing Director of Wyeth for the Middle East and Africa (MEA). Joe led Wyeth MEA to an unprecedented growth during his time; the affiliate structure grew from 150 employees to over 500 employees and increased revenues multi-fold to around $450 million in the five-year period from 2004-2009. These record achievements marked the MEA as one of the top fastest growing affiliates in Wyeth.

Prior to his role with Wyeth in Dubai, Joe led key global therapeutic areas, from the World Headquarters of Wyeth in the US, most notably infectious diseases as VP and Global Commercial Chair, and served in a senior operational role for MEA and Central Eastern Europe (CEE). Joe also served in various corporate and industry committees; including Wyeth Development Council, Wyeth Development Strategy Board, and Wyeth European Operation Council. On the industry level, he most recently served as the Vice Chair for the PhRMA MEA Committee and the Chair of the PhRMA MEA Ethics Review Board.

"I am excited to join NewBridge at such a critical point in its growth," commented Mr. Henein. "I look forward to working closely with the Board, Management, and employees of NewBridge to establish a strong regional presence, expand the breadth of our commercialization excellence, and build value for the company, shareholders and our customers in the region."

NewBridge also announced the appointment of G. Garrett Vygantas, M.D. as Vice Pres
'/>"/>

SOURCE NewBridge Pharmaceuticals Ltd.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
2. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
4. Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
6. ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
7. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
8. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
9. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
10. Access Pharmaceuticals Launches MuGard Product Website
11. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15

Post Your Comments:

(Date:5/20/2013)... LONDON , BERLIN and ... -- Arthroscopy Devices Market to 2018 ... Minimally Invasive Procedures to Drive Future Growth" looks at ... the six arthroscopy device market segments: arthroscopes, arthroscopy shavers, ... frequency systems, and arthroscopy visualization systems. The report provides ...

(Date:5/20/2013)... 2013 Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...

(Date:5/20/2013)... , May 20, 2013 With herbal ... resource available from the U.S. Pharmacopeial Convention (USP) will ... quality of the herbal ingredients used in these products. ... included in the new Herbal Medicines Compendium ... worldwide at hmc.usp.org . HMC ...

Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3

[0] Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth [0] Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania [0] New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines

... Reportlinker.com announces that a new market research report ... Nephrology and Urology Devices Market Outlook to 2017 ... and Urology Devices Market Outlook to 2017 ... Nephrology and Urology Devices Market Outlook to 2017" provides ...

... Reportlinker.com announces that a new market research ... Continuous Glucose Monitoring (CGM) Systems ... Market Forecasts to 2016 ... Monitoring (CGM) Systems - Global Pipeline Analysis, ...

Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

(Date:5/20/2013)... May 2013 While Huntington,s disease (HD) is ... new disease-modifying therapies in development may slow or ... research depends upon the identification of reliable and ... and these biomarkers may eventually be used as ... especially helpful to monitor changes during the time ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 ... adult allogeneic stem cell manufacturing, research and development, ... of Medicine and Director of Interventional Cardiology Research ... join the Scientific and Medical Advisory Board for ... of Pennsylvania, Dr. Wilensky divides his time between ...

(Date:5/20/2013)... of the much-anticipated Second Edition of The Biology of ... Edition has been hailed as an incomparable classic. Thoroughly ... fast-growing field of cancer biology, The Biology of Cancer, ... by students, instructors, researchers, and clinicians around the world. ... students studying the molecular and cellular bases of cancer ...

(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Boys who are ... likely to become obese adults as those who didn,t ... 30-year study shows. Researchers found that men with ... (BMI) and obesity, even if they no longer had ... well-off or poor, they tended toward obesity. "The ...

(Date:5/20/2013)... NY (PRWEB) May 20, 2013 In ... of the numerous scientific accomplishments achieved at The ... group of female scientists, Advancing Women in Science ... breakfast on May 17. Scientists, educators, business and ... celebrate excellence and achievements of women in science. ...

Breaking Medicine News(10 mins):Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2 Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3 Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2 Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3 Health News:'The Biology of Cancer' by Robert A. Weinberg 2 Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2 Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3 Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2 Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3

[0] Leading researchers report on the elusive search for biomarkers in Huntington's disease [0] Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board [0] 'The Biology of Cancer' by Robert A. Weinberg [0] ADHD in Childhood May Raise Risk for Obesity in Adulthood [0] North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week

... can do a lot to keep kids safe, experts say, , ... to be), youngsters are probably going to be spending less ... doing cannonballs. , It,s all fun and games -- until someone ... warn child safety experts. , Though many injuries amount to little ...

... Invited to Attend , , NEW ORLEANS, June 6 ... New Orleans for the 2009 Catholic Health Assembly, "In Our ... , The assembly, hosted by the Catholic Health Association of ... Catholic health care leaders from across the nation. They come ...

... ... Low Vision Conditions , ... Beach, CA (PRWEB) June 6, 2009 -- Enhanced Vision , America,s leading manufacturer of ... VISION 5K Run & Walk in Boston, MA this Saturday, June 7th. The unique event ...

... , - These acquisitions reinforce Genomma Lab,s presence in the cosmetics ... lotions and perfumes segments , , - Genomma Lab continues ... place in June 2008 , , ... C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of ...

... study found diabetes drug didn,t increase chances of heart disease, ... drug Avandia significantly raises the risk of both heart failure ... for either cardiovascular disease or death, new research has found. ... risk of death, said the authors of the much-anticipated RECORD ...

... June 5 NxStage Medical, Inc. (Nasdaq: ... today announced it has completed the closing of its ... alliance partner, Asahi Kasei Kuraray Medical. The Company used ... its entire debt obligation, including prepayment and other transaction ...

Cached Medicine News:Health News:Summer Fun Need Not Be Hazardous 2 Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 2 Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 3 Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 2 Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 3 Health News:Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns 2 Health News:Avandia Raises Risk of Heart Failure, Fractures 2 Health News:Avandia Raises Risk of Heart Failure, Fractures 3 Health News:Avandia Raises Risk of Heart Failure, Fractures 4 Health News:NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical 2

Summer Fun Need Not Be Hazardous 2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns Avandia Raises Risk of Heart Failure, Fractures NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical

Designed to securely hold scleral plugs during insertion and removal. The cross action handle is designed to reduce hand fatigue while grasping plug....

Ergotec Vetriretinal Instrument System. Ultra-fine 3.35 mm jaws. Angled 55 degrees. 20 gauge shaft. 30 mm in length. Blackened tip. Overall length from rear rotation knob to tip....

Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....

Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....

Medicine Products:

Scleral Plug Forceps Subretinal Forcep Black Long Jameson Muscle Forceps - Left Trouan Superior Rectus Forceps